Swiss National Bank Athersys, Inc Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$0.85 - $1.4 $375,445 - $618,380	-441,700 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$1.33 - $1.77 $16,758 - $22,302	12,600 Added 2.94%	441,700 $587,000
Q1 2021 May 07, 2021	BUY	$1.61 - $2.77 $20,125 - $34,625	12,500 Added 3.0%	429,100 $772,000
Q2 2020 Aug 05, 2020	BUY	$1.97 - $3.98 $820,702 - $1.66 Million	416,600 New	416,600 $1.15 Million

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.